Fitzgerald Joseph Michael
EVP & Group Pres, Cardiology
Fitzgerald Joseph Michael has filed 6 SEC Form 4 filings (22 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Feb 18, 2026.
On the most recent filing, Fitzgerald Joseph Michael is listed as EVP & Group Pres, Cardiology at BOSTON SCIENTIFIC CORP. Inside the rolling window, Fitzgerald Joseph Michael reported no open-market purchases and 1 open-market sale totaling $5.0M in BSX.
Companies traded
Other insiders at BSX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$5.0M
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Oct 1, 2025 | BSX | Sale | $4.1M |
| Oct 1, 2025 | BSX | Sale | $815K |
| Sep 2, 2025 | BSX | Sale | $3.0M |
| Sep 2, 2025 | BSX | Sale | $2.3M |
Frequently asked questions
How many SEC Form 4 filings has Fitzgerald Joseph Michael made?
Fitzgerald Joseph Michael has filed 6 SEC Form 4 filings (22 transaction rows) across 1 company since 2025.
Which companies does Fitzgerald Joseph Michael trade?
Fitzgerald Joseph Michael has filed SEC Form 4 disclosures for 1 company, including BSX.
When was Fitzgerald Joseph Michael's most recent SEC Form 4 filing?
Fitzgerald Joseph Michael's most recent SEC Form 4 filing on Tracefour is dated Feb 18, 2026.
What is Fitzgerald Joseph Michael's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Fitzgerald Joseph Michael is listed as EVP & Group Pres, Cardiology.
What is Fitzgerald Joseph Michael's total buy and sell value in the current window?
Inside the rolling retention window, Fitzgerald Joseph Michael bought $0 and sold $5.0M based on SEC Form 4 filings.
What was Fitzgerald Joseph Michael's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 50,000 BSX shares on 2025-11-03, worth $5.0M, per SEC Form 4 filings.